Brief: Avenue Therapeutics Says On July 17 Nasdaq Granted Co's Request For Extension Of Deadline To Regain Compliance With Listing Rule To November 15
21/07/2023 21:42
July 21 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS INC - ON JULY 17 NASDAQ GRANTED CO'S
REQUEST
FOR EXTENSION OF DEADLINE TO REGAIN COMPLIANCE WITH LISTING RULE
TO NOVEMBER 15
Further company coverage: ATXI.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary